[ad_1] We are self-sufficient in agriculture produce, thanks to the Green Revolution. But the negative environmental impacts in green revolution regions are all too visible — soil degradation, biodiversity loss,…
Tag: PDS
PDS Biotech Announces PDS0101 Combined with Chemoradiotherapy Associated with Rapid Decline in Circulating Tumor DNA (ctDNA/cfDNA)
[ad_1] Study evaluated levels of circulating cell-free HPV DNA (cfDNA) in patients with locally advanced cervical cancer in the IMMUNOCERV Phase 2 clinical trial and patients receiving standard of care…
PDS Biotech to Present at the LD Micro Main Event XVI
[ad_1] PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer…
PDS Biotech to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
[ad_1] PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer…
Thermatic Technical FM announces acquisition of PDS Drainage Solutions – Business Leader News
[ad_1] Thermatic Technical FM announces acquisition of PDS Drainage … Business Leader [ad_2] Source link
Drilling Stocks Plunge on Bets for Oil Price Slump
[ad_1] Shares of onshore drillers have fallen steeply after a wave of recent rig idlings, which investors fear could signal a coming drop in oil demand amid a slowing economy.…
PDS celebrates 20 years of business
[ad_1] Date published: 13 April 2023 PDS celebrates turning 20: 20 of the company’s longest-serving employees Local door manufacturer Performance Doorset Solutions (PDS) has just celebrated its 20th anniversary.…
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
[ad_1] FLORHAM PARK, N.J., March 30, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and infectious…